No Time to Lose: Cases of Anticoagulant Reversal Before Thrombolysis in Acute Ischemic Stroke Patients

Direct oral anticoagulant (DOAC) reversal before intravenous thrombolysis (IVT) in acute ischemic stroke (AIS) patients is well-documented in Europe, specifically for dabigatran: the selective humanized monoclonal antibody fragment idarucizumab, given to neutralize dabigatran prior to IVT, was assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Sheyar, Kasischke, Karl A, Elsayed, Kareem, Burgin, W. Scott, Rose, David Z
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856630/
https://www.ncbi.nlm.nih.gov/pubmed/35198313
http://dx.doi.org/10.7759/cureus.21406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856630/
https://www.ncbi.nlm.nih.gov/pubmed/35198313
http://dx.doi.org/10.7759/cureus.21406

Ejemplares similares